Browsing byAuthorBabl, FE

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 6 to 11 of 11< previous 
Issue DateTitleAuthor(s)
2021-02-03Managing low‐risk febrile neutropenia in children in the time of COVID‐19: What matters to parents and cliniciansHaeusler, GM; De Abreu Lourenco, R; Bakos, C; O'Brien, T; Slavin, MA; Clark, JE; McMullan, B; Borland, ML; Babl, FE; Krishnasamy, M; Vanevski, M; Thursky, KA; Hall, L
2017-07-11Predicting Infectious ComplicatioNs in Children with Cancer: An external validation studyHaeusler, GM; Thursky, KA; Mechinaud, F; Babl, FE; De Abreu Lourenco, R; Slavin, MA; Phillips, R
2022-10Prevalence and predictors of poor outcome in children with febrile neutropaenia presenting to the emergency department.Long, E; Babl, FE; Phillips, N; Craig, S; Zhang, M; Kochar, A; McCaskill, M; Borland, ML; Slavin, MA; Phillips, R; Lourenco, RDA; Michinaud, F; Thursky, KA; Haeusler, G; Australian PICNICC Study Group and the PREDICT Network,
2021-05-20Procalcitonin and Interleukin-10 May Assist in Early Prediction of Bacteraemia in Children With Cancer and Febrile NeutropeniaDoerflinger, M; Haeusler, GM; Li-Wai-Suen, CSN; Clark, JE; Slavin, M; Babl, FE; Allaway, Z; Mechinaud, F; Smyth, GK; De Abreu Lourenco, R; Phillips, B; Pellegrini, M; Thursky, KA
2020Re-evaluating and recalibrating predictors of bacterial infection in children with cancer and febrile neutropeniaHaeusler, G; Thursky, K; Slavin, MA; Babl, FE; De Abreu Lourenco, R; Mechinaud, F; Phillips, B
2020-01-01Risk stratification in children with cancer and febrile neutropenia: A national, prospective, multicentre validation of nine clinical decision rulesHaeusler, GM; Thursky, KA; Slavin, MA; Babl, FE; De Abreu Lourenco, R; Allaway, Z; Mechinaud, F; Phillips, R